Polaryx Therapeutics, Inc. (PLYX): Submission of Matters to a Vote of Security Holders

SciSparc (SPRC) shares rose ~140% after its TSX Venture subsidiary received conditional approval to buy ~54% of private Israeli CliniQuantum for 56.6M NeuroThera shares (~$9.46M). Co-Diagnostics (CODX) gained ~53% for a third day amid Ebola PCR assay progress. Akari (AKTX) jumped ~38% on ASCO abstract acceptance and new KRAS-mutant synergy data; Outlook (OTLK) rose ~26% ahead of a June FDA resubmission.

Polaryx Therapeutics said it completed a PIPE financing of 2,502,696 shares at an average ~$4 per share, with no SEC registration statement for resale. The company plans to use $10 million gross proceeds plus existing cash to start its Phase 2 SOTERIA basket trial for PLX-200 across four LSDs, extending runway to Q2 2027. Shares were up 8.76% to $2.73.

Minerals Technologies (MTX) completed a $400 million offering of 7.50% Senior Notes due 2032 to refinance 2028 debt and expanded its revolving credit facility to $500 million, maturing in 2031. The moves aim to strengthen liquidity and extend debt maturities, according to the company.

Equus Total Return, Inc. received a notice from the NYSE for failing to meet the $1.00 average closing price rule over 30 days. The company plans to address this within six months, possibly through a reverse stock split.

Micron Technology (MU) increased its share buyback authorization to $35.16 billion, over four times its spending in the past eight years. The move follows a surge in free cash flow, with $33.2 billion generated in Q4 2026 alone. Management expects continued strong cash flow and intends to increase capital returns. However, buybacks may be limited by CHIPS Act conditions and recent stock price increases.

Illumina established a $1.0 billion unsecured commercial paper program for general corporate purposes. The program allows short-term notes with maturities up to 397 days. A national bank will serve as the issuing and paying agent, with three dealers initially participating. No notes were outstanding as of the filing date.